Photo Cred: Karolina Grabowska/Pexels By Katherine Shagoury The AstraZeneca novel coronavirus (COVID-19) vaccine candidate, AZD1222, demonstrated 79 percent efficacy at preventing symptomatic COVID-19 and 100 percent efficacy at preventing severe...
Read MorePhoto Cred: Integrative Practitioner By Katherine Shagoury The Integrative Healthcare Symposium event organizers announced new dates for its 2021 edition of the in-person conference, produced by Diversified Communications, according to...
Read MorePhoto Cred: Pixabay By Katherine Shagoury Fully vaccinated individuals can visit each other mask-free, according to the latest guidance from the U.S. Centers for Disease Control and Prevention (CDC). On...
Read MorePhoto Cred: Anna Shvets/Pexels By Katherine Shagoury The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have the novel coronavirus (COVID-19), according to...
Read MorePhoto Cred: Thirdman/Pexels By Katherine Shagoury The U.S. Food and Drug Administration (FDA) issued late last week an emergency use authorization for the third novel coronavirus (COVID-19) vaccination, the Janssen...
Read MorePhoto Cred: Fauxels/Pexels By Katherine Shagoury Racism and discrimination exist prominently in healthcare. Racial disparities in medicine are not only the result of individual actions, but of deeply engrained structural...
Read MorePhoto Cred: Mehmet Turgut Kirkgoz/Unsplash By Katherine Shagoury The United States will have enough supply of the novel coronavirus (COVID-19) vaccination to cover 300 million Americans by the end of...
Read MorePhoto Cred: CDC/Unsplash By Katherine Shagoury Johnson and Johnson submitted an application to the U.S. Food and Drug Administration (FDA) on Thursday, requesting emergency use authorization for its single-dose novel...
Read More